Daratumumab versus lenalidomide maintenance therapy for multiple myeloma: A randomized pilot study comparing patient-reported health related quality of life measures Meeting Abstract
| Authors: | Shah, U. A.; Malik, M.; Werner, K.; Burge, M.; Devlin, S. M.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; Maclachlan, K. H.; Lu, S. X.; Patel, D.; Hamilton, A.; Scordo, M.; Dahi, P. B.; Lahoud, O. B.; Chung, D. J.; Landau, H. J.; Shah, G. L.; Giralt, S. A.; Lesokhin, A.; Landgren, O. |
| Abstract Title: | Daratumumab versus lenalidomide maintenance therapy for multiple myeloma: A randomized pilot study comparing patient-reported health related quality of life measures |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000835740102230 |
| DOI: | 10.1182/blood-2021-150684 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4762 -- Hybrid meeting, also took place online -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
